News about Manufacturing

FDA Launches PreCheck Program to Boost US Drug Manufacturing

FDA Launches PreCheck Program to Boost US Drug Manufacturing

The US Food and Drug Administration (USFDA) has unveiled a new program aimed at strengthening the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the construction of manufacturing sites in the United States.

Manufacturing | 11/08/2025 | By Dineshwori 211

SCHOTT Expands Manufacturing in Gujarat, Becomes Asia's Largest Producer of Syringe and Cartridge Glass Tubing

SCHOTT Expands Manufacturing in Gujarat, Becomes Asia's Largest Producer of Syringe and Cartridge Glass Tubing

SCHOTT, a global leader in specialty glass, has announced the expansion of its manufacturing facility in Jambusar, Gujarat, by adding syringe and cartridge glass tubing production capabilities.

Manufacturing | 07/08/2025 | By Darshana 670

Eris Lifesciences Reports 41% PAT Growth in Q1 FY26, Strengthens Manufacturing and Branded Formulations Portfolio

Eris Lifesciences Reports 41% PAT Growth in Q1 FY26, Strengthens Manufacturing and Branded Formulations Portfolio

Eris Lifesciences Limited, one of India’s leading branded formulations manufacturers, has reported a strong financial and operational performance for the first quarter of FY26. Consolidated revenue grew by 7.4% year-over-year, largely fueled by an 11% rise in its domestic branded formulations business.

Manufacturing | 07/08/2025 | By Darshana 303

Sandoz to Acquire Evotec's Toulouse Facility for About USD 300 Million to Boost Biosimilar Manufacturing

Sandoz to Acquire Evotec's Toulouse Facility for About USD 300 Million to Boost Biosimilar Manufacturing

Sandoz, a global leader in generics and biosimilars, has signed a non-binding term sheet to acquire Evotec SE’s Just-Evotec Biologics EU SAS, including the state-of-the-art J.POD biologics development and manufacturing facility in Toulouse, France.

Manufacturing | 06/08/2025 | By Darshana 467

Axplora Expands Vizag API Facility After Successful USFDA Inspections at Indian Sites

Axplora Expands Vizag API Facility After Successful USFDA Inspections at Indian Sites

The move comes after both of Axplora’s Indian manufacturing sites—Vizag and Chennai—operating under its PharmaZell Business Unit, successfully cleared routine inspections by the US Food and Drug Administration (USFDA) in 2025, receiving a Voluntary Action Indicated (VAI) classification.

Manufacturing | 06/08/2025 | By Darshana 322

WuXi XDC Secures GMP Release of Newly Launched DP3 Facility at Wuxi Site

WuXi XDC Secures GMP Release of Newly Launched DP3 Facility at Wuxi Site

WuXi XDC Cayman Inc. has announced the GMP release of its high-capacity DP3 facility at the Wuxi site, expanding its bioconjugate drug product manufacturing to 15 million vials annually.

Manufacturing | 06/08/2025 | By Mrinmoy Dey 217

Laxmi Dental to Acquires 58 Percent Stake in AI Dent, Expand Digital Dentistry Capabilities

Laxmi Dental to Acquires 58 Percent Stake in AI Dent, Expand Digital Dentistry Capabilities

Laxmi Dental is set to acquire a majority stake in AI Dent, a Gujarat-based healthcare technology company focused on artificial intelligence applications in dentistry, to advance AI-powered dentistry in India.

Manufacturing | 04/08/2025 | By Dineshwori 792

Iberia Pharmaceuticals Invests INR 70 Crore to Build Hi-Tech Manufacturing and R&D Facility in Haryana

Iberia Pharmaceuticals Invests INR 70 Crore to Build Hi-Tech Manufacturing and R&D Facility in Haryana

Equipped with advanced control systems and best-in-class equipment, the plant will support large-scale commercial manufacturing without compromising on international quality standards.

Manufacturing | 01/08/2025 | By Darshana 284

Symbiosis Marks Milestone with 1,000th Sterile Drug Manufacturing Batch

Symbiosis Marks Milestone with 1,000th Sterile Drug Manufacturing Batch

A significant highlight in its journey was its contribution to the development of the Oxford University/AstraZeneca COVID-19 vaccine, where the company produced nearly one million doses at its Stirling facility to support clinical trials and regulatory approvals in the UK.

Manufacturing | 31/07/2025 | By Darshana 145

Bachem Reports Strong H1 Results, Plans USD 460 Million Investment to Expand Manufacturing Capacity in 2025

Bachem Reports Strong H1 Results, Plans USD 460 Million Investment to Expand Manufacturing Capacity in 2025

Bachem, a leading Swiss manufacturer of peptides and oligonucleotides, reported robust financial results for the first half of 2025 and unveiled plans to invest USD 460 million over the year to expand its global manufacturing footprint.

Manufacturing | 29/07/2025 | By Darshana 1157

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members